| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hematologic Neoplasms | D019337 | 4 associated lipids |
| Darier Disease | D007644 | 2 associated lipids |
| Endometrial Neoplasms | D016889 | 30 associated lipids |
| Trypanosomiasis, African | D014353 | 5 associated lipids |
| Retinoblastoma | D012175 | 12 associated lipids |
| Lymphoma, B-Cell | D016393 | 24 associated lipids |
| Carcinoma, Mucoepidermoid | D018277 | 3 associated lipids |
| Lung Injury | D055370 | 14 associated lipids |
| Retinal Neoplasms | D019572 | 3 associated lipids |
| Prostatic Neoplasms, Castration-Resistant | D064129 | 3 associated lipids |
Gossypol
Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.
Cross Reference
Introduction
To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Gossypol?
Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Gossypol
PubChem Associated disorders and diseases
What pathways are associated with Gossypol
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Gossypol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Gossypol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Gossypol?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Gossypol?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Gossypol?
Xenograft Model
Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).
Transgenic Model
Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Gossypol
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ready N et al. | Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. | 2011 | J Thorac Oncol | pmid:21289522 |
| Li H et al. | Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells. | 2011 | Pharm. Res. | pmid:21710341 |
| Dash R et al. | Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21555592 |
| Pang X et al. | (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis. | 2011 | Mol. Cancer Ther. | pmid:21372225 |
| Guo Z et al. | [Gossypol acetic acid induces DNA double-strand breaks in human mucoepidermoid carcinoma cell MEC-1]. | 2011 | Sheng Li Xue Bao | pmid:21505732 |
| Ma X et al. | Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2. | 2011 | Toxicology | pmid:21515335 |
| Akagunduz O et al. | Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment. | 2010 Oct-Dec | J BUON | pmid:21229643 |
| Tiliabaev KZ et al. | [Synthesis, structures, and acute toxicity of gossypol nonsymmetrical aldehyde derivatives]. | 2010 May-Jun | Bioorg. Khim. | pmid:20644599 |
| Chang Q et al. | Effects of combined administration of low-dose gossypol with steroid hormones on the mitotic phase of spermatogenesis of rat. | 2010 | J Exp Zool A Ecol Genet Physiol | pmid:20839281 |
| Uzunoglu S et al. | Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (-/- gossypol). | 2010 | Toxicol. Mech. Methods | pmid:20843265 |
| Przybylski P et al. | The influence of protonation on molecular structure and physico-chemical properties of gossypol Schiff bases. | 2010 | Org. Biomol. Chem. | pmid:20959900 |
| Vizirianakis IS et al. | Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives. | 2010 | J. Med. Chem. | pmid:20925433 |
| Zwitter M | Combining cytotoxic and targeted therapies for lung cancer. | 2010 | J Thorac Oncol | pmid:20871258 |
| Lian J et al. | The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells. | 2010 | Autophagy | pmid:20930561 |
| Goldsmith KC et al. | BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists. | 2010 | Cell Death Differ. | pmid:19893570 |
| Wei J et al. | BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. | 2010 | J. Med. Chem. | pmid:20443627 |
| Voss V et al. | The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. | 2010 | Mol. Cancer Res. | pmid:20587533 |
| McGregor N et al. | AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model. | 2010 | J. Cell. Biochem. | pmid:20589722 |
| Zhang XQ et al. | Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro. | 2010 | Asian J. Androl. | pmid:20657602 |
| Li G et al. | [Effect of testosterone on the expression of CMTM family of the male spermatogenesis suppression rats]. | 2010 | Yao Xue Xue Bao | pmid:21351585 |